Navigation Links
Biotechnology Pharmaceutical Company Selects NewCardio's QTinno for Thorough QT Trial
Date:1/11/2012

iable, automated identification of key cardiac events. Pharmaceutical sponsors and clinical research organizations, which are mandated by the FDA to test new drugs for potential cardiac toxicity, are expected to benefit from QTinno's faster, more accurate and less expensive assessment of cardiac status.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company developing and marketing proprietary software platform technologies to provide higher accuracy to, and increase the value of, the standard 12-lead ECG.  NewCardio's 3-D ECG software platform reduces the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect.  NewCardio's software products and services significantly improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development. For more information, visit www.newcardio.com.

Forward-Looking Statements   

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. Thes
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
(Date:7/31/2014)... 2014  A substantial share of pharmacy and ... therapies are included in formularies—say patient support resources ... new Manhattan Research study, Taking the Pulse® ... that P&T committee members in hospitals, managed care ... set a high bar for these programs, requiring ...
(Date:7/31/2014)... Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval inspection ... The inspection, carried out by the FDA Consumer Safety Officer, ... planned, started on 21 st July and concluded on ... be compliant with the principles and guidelines of Good Manufacturing ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2
... College of American Pathologists Outlines Recommendations at Food and Drug ... , ... increasing importance of laboratory tests in diagnosing and treating disease, representatives ... the Food and Drug Administration (FDA) urging increased oversight of laboratory ...
... CHICAGO and PASADENA, Calif. , July 20 ... that Huntington Memorial Hospital has selected the Allscripts ... Exchange (HIE) that enables physicians, hospitals and other health care providers ... team approach to patient care, regardless of where they are located ...
Cached Medicine Technology:CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 2CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 3CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 2Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 3Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 4Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 5Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 6Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community 7
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... HealthDay Reporter , THURDAY, July 31, 2014 (HealthDay ... cafeteria fare, a new study suggests. The new research ... fourth graders brought from home met three of five National ... similar to results of other studies of children,s packed lunches ... foods and beverages are more common than fruits, vegetables and ...
(Date:8/1/2014)... older women with asthma often have worse health outcomes, they ... new study. "There is no doubt that women over ... concluded Dr. James Sublett, an allergist and president-elect of the ... organization news release. In fact, the asthma death rate ... times higher than in other groups of people, the study,s ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 For the ... their Organic Cotton Farm & Fiber Report and the ... for the entire organic cotton supply chain resulting in ... Pepper, the organization’s Managing Director, reports, “We are looking ... farmers are the beginning of a long value chain ...
(Date:8/1/2014)... August 01, 2014 Did you know that ... Sarcoma Awareness Month is to raise awareness across the country ... options for, sarcoma. According to the American Cancer Society, nearly ... 2014, while 12,000 new soft tissue sarcomas will be diagnosed. ... sarcoma tumors as they are other kinds of cancer,” said ...
Breaking Medicine News(10 mins):Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Older Women With Asthma Face Worse Health Outcomes 2Health News:Surveys Reveal the Top 10 Organic Cotton Users and the Top 10 Producing Countries 2Health News:July Was Sarcoma Awareness Month! 2Health News:July Was Sarcoma Awareness Month! 3Health News:July Was Sarcoma Awareness Month! 4
... Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a ... non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and ... provided a business update, and management reiterated its expectation ... completes the development and regulatory review of its lead ...
... ... ... is a critical piece of a healthy lifestyle, however, those who suffer from diabetes may ... of Sports Health: A Multidisciplinary Approach. Authors confirm that exercise can aid in diabetes treatment ...
... ... The Real Housewives of Orange County ,” Dr. Milind Ambe consulted with Lynne Curtin’s ... Orange County breast augmentation with the 19 year-old. , ... (Vocus) December 29, 2009 -- Newport Beach ...
... ... Texas, announced today that it has expanded its’ continuum of care with the addition of ... ... announced today that it has expanded its’ continuum of care to include Origins owned and ...
... , Department of Health Urges All Pennsylvanians ... federal Centers for Disease Control and Prevention, or CDC, has ... to Pennsylvania to date, the state Department of Health said ... certified providers, local health departments, and state health centers. ...
... have identified a role for enhanced activation of the ... either the TSC1 or the TSC2 protein. As indicated ... in an accompanying commentary, these data provide a rationale ... those with TSC-associated tumors. Tuberous sclerosis complex (TSC) ...
Cached Medicine News:Health News:Echo Therapeutics Provides Business Update 2Health News:Echo Therapeutics Provides Business Update 3Health News:Echo Therapeutics Provides Business Update 4Health News:Echo Therapeutics Provides Business Update 5Health News:Exercise May Reduce the Complications of Diabetes, According to Sports Health Journal Study 2Health News:Exercise May Reduce the Complications of Diabetes, According to Sports Health Journal Study 3Health News:Newport Beach Plastic Surgeon Educates About the Pros and Cons of Plastic Surgery 2Health News:Newport Beach Plastic Surgeon Educates About the Pros and Cons of Plastic Surgery 3Health News:Origins Recovery Centers Announces an Expansion of its Continuum of Care 2Health News:Origins Recovery Centers Announces an Expansion of its Continuum of Care 3
Micro-mini fiber optic light....
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Delivers one primary lamp and one backup lamp. The port accepts ACMI fiberoptic cables....
Medicine Products: